Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Lowered to $855 at Piper Sandler Following Setback

May 18, 2026 7:45 AM
(Updated - May 18, 2026 9:17 AM EDT)

Piper Sandler analyst Biren Amin lowered the price target on Regeneron ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change